Thank you


Thank you to all who joined us live for our first virtual conference on May 8. If you were not able to join us live, most sessions have been recorded and are available now.


Save the Date

PrimaryCareNOW: A Virtual CME Conference
Friday, June 26, 2020
8am–5:30pm EDT

Save the date for our next virtual conference, featuring all-new evidence-based sessions to provide you with the most current clinical strategies relevant to your daily practice. Registration will be opening soon at www.pri-med.com.

PrimaryCareNOW offers the same high-quality medical education clinicians have come to expect at our in-person conferences, in an all-new, all-digital format.
This full day of virtual education will provide you with evidence-based sessions that span the diverse therapeutic areas that touch primary care, provide opportunities for interactive Q&A, and offer timely medical updates to keep you informed on the most current clinical strategies relevant to your daily practice.
Earn up to 6.00 AMA PRA Category 1 Credits™ or AANP contact hours during one full day of FREE online education.
Your registration includes the full day, but feel free to join the sessions that work with your schedule. 

Agenda

  CME/CE Accredited Session

Non CME/CE Session
Sponsored by Industry

Click For Session Details
Session Times Listed in EDT

8–9am

Cardiology

What Clinicians Need to Know About the Cardiovascular Complications of COVID-19

Peter Libby, MD | Erin Bohula, MD, DPhil

With the COVID-19 pandemic moving through the country, it is important for clinicians to have the most up-to-date information. Join this session with Dr. Peter Libby to learn about the cardiovascular complications of COVID-19 and how you can help patients facing these issues.

Peter Libby

Peter Libby, MD

Cardiovascular Specialist, Brigham and Women's Hospital, Boston, MA; Mallinckrodt Professor of Medicine, Harvard Medical School, Boston, MA

Erin Bohula

Erin Bohula, MD, DPhil

Cardiac Intensivist, Brigham & Women's Hospital; Investigator, TIMI Study Group; Instructor, Harvard Medical School, Boston, MA

9:15–10:15am

Pulmonology

Severe Asthma in Primary Care: New Strategies for Management

Christopher H. Fanta, MD | Gerald W. Smetana, MD

The most recent CDC report estimates an asthma prevalence of 7.9% in the U.S. Although patients with severe asthma make up only 3–10% of the total asthma population, they account for a substantial proportion of asthma morbidity and health expenditures. With the emergence of new biologic therapies targeting cytokines involved in pathogenesis of asthma, severe asthma is no longer considered the “refractory” disease of yesteryear. This session offers guidance on distinguishing characteristics pertinent to individualizing asthma treatment, such as subtype, phenotype, and endotype as well as biomarkers and other measures of assessment that identify patients with severe eosinophilic asthma. Using expert guidelines, the faculty will discuss how to apply these individual factors to treatment management and alleviate the burden of asthma in your practice.

Christopher Fanta

Christopher H. Fanta, MD

Professor of Medicine, Harvard Medical School, Boston, MA; Director, Partners Asthma Center, Member, Pulmonary and Critical Care Division, Brigham and Women's Hospital, Boston, MA

Gerald Smetana

Gerald W. Smetana, MD

Professor of Medicine, Harvard Medical School, Boston, MA; Clinician Educator, Division of General Medicine and Primary Care, Beth Israel Deaconess Medical Center, Boston, MA

Supported by GlaxoSmithKline

10:30–11:30am

Infectious Disease

Managing Influenza: Updates and Practical Strategies for Primary Care

Paul E. Sax, MD | Daniel Solomon, MD | Charles Vega, MD, FAAFP

Is influenza going viral in your practice? This session on influenza diagnosis and management will improve how you respond when annual fluctuations in vaccine efficacy expose your patients to risk of serious illness. Through interactive patient cases, the faculty will demonstrate how to identify and treat patients with suspected influenza, including patients at high risk for complications. These practical, evidence-based strategies will help you to use antiviral medications effectively and reduce the burden of influenza.

Paul Sax

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; Professor of Medicine, Harvard Medical School, Boston, MA

Daniel Solomon

Daniel Solomon, MD

Associate Physician, Brigham and Women's Hospital; Professor of Medicine, Harvard Medical School

Charles Vega

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine

Supported by Genentech

11:45am–12:15pm

Industry Theater

Uncontrolled Asthma: Changing the Patient Experience

Anne Marie Ditto, MD

In this session, Dr. Ditto will use a case presentation to discuss the impact of uncontrolled asthma and tools for assessing asthma control as well as asthma management. Learn to identify ways to customize management of uncontrolled asthma by pairing the right medications with the right patients.

Anne Marie Ditto

Anne Marie Ditto, MD

Sponsored by GlaxoSmithKline

12:15–12:45pm

Industry Theater

COPD: Simplifying a Complex Paradigm for Busy Clinicians

Tom Corbridge, MD, FCCP

This session will provide clinically relevant information regarding the management of patients with COPD and focuses on establishing a valid diagnosis, avoiding common pitfalls in assessment, reducing symptoms and preventing exacerbations.

Tom Corbridge

Tom Corbridge, MD, FCCP

Sponsored by GlaxoSmithKline

1–2pm

Infectious Disease

COVID-19 Panel Discussion

Frank J. Domino, MD | Paul E. Sax, MD | Laila Woc-Colburn, MD

These troubling times require communication among specialists and primary care. In this COVID-19 panel, primary care and infectious disease faculty will team up to discuss the most pressing and frequently asked questions about this disease and its complications.

Frank Domino

Frank J. Domino, MD

Professor, Family Medicine and Community Health, University of Massachusetts Medical School, Worcester, MA

Paul Sax

Paul E. Sax, MD

Clinical Director, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA; Professor of Medicine, Harvard Medical School, Boston, MA

Laila Woc-Colburn

Laila Woc-Colburn, MD

Associate Professor, Section of Infectious Diseases, Department of Medicine, National School of Tropical Medicine, Baylor College of Medicine, Houston, TX

2:15–3:15pm

Cardiology / Endocrinology

The Heart of the Matter: Primary and Secondary Prevention of Cardiovascular Disease in T2DM

Martin J. Abrahamson, MD, FACP | Charles Vega, MD, FAAFP

Adults with type 2 diabetes mellitus (T2DM) have a two- to four-fold increase in risk for cardiovascular (CV) morbidity and mortality. This session cuts to the heart of primary and secondary prevention in this population, presenting recent data on antihyperglycemic medications with proven cardiovascular benefit in the context of updated management algorithms. Individualized treatment is critical to the success of these treatment plans. The faculty will help you optimize adherence through shared decision-making tactics that account for CV risk factors, comorbidities, and patient preferences.

Martin Abrahamson

Martin J. Abrahamson, MD, FACP

Associate Professor of Medicine, Harvard Medical School; Director, Division of CME, Beth Israel Medical Center, Beth Isreal Deaconess Medical Center, Boston, MA

Charles Vega

Charles Vega, MD, FAAFP

Health Sciences Clinical Professor, UC Irvine Department of Family Medicine, Assistant Dean for Culture and Community Education, UC Irvine School of Medicine; Executive Director, UC Irvine Program in Medical Education for the Latino Community, UC Irvine School of Medicine

Supported by Lilly. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

3:30–4:30pm

Nephrology

Chronic Kidney Disease: A Primer for Pri-Med

Melanie Hoenig, MD

Chronic kidney disease is common, yet many clinicians find it intimidating to manage. This session will give you the tools that you need to identify renal disease, recognize which patients are at risk for a decline in renal function, and practice the components of care.

Melanie Hoenig

Melanie Hoenig, MD

Associate Professor, Harvard Medical School, Boston, MA

4:45–5:30pm

Industry Theater

The Burden and Management of Moderate-to-Severe Atopic Dermatitis in Patients 12 Years of Age or Older

Peter Lio, MD

Come learn about the burden and management of uncontrolled, moderate-to-severe atopic dermatitis in your patients (12+ years of age) and a treatment option that may help them.

Peter Lio

Peter Lio, MD

Assistant Professor of Clinical Dermatology and Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, Illinois

Sponsored by Regeneron and Sanofi Genzyme

Faculty

Martin J. Abrahamson, MD, FACP
Erin Bohula, MD, DPhil
Frank J. Domino, MD
Christopher H. Fanta, MD
Melanie Hoenig, MD
Peter Libby, MD
Paul E. Sax, MD
Gerald W. Smetana, MD
Daniel Solomon, MD
Charles Vega, MD, FAAFP
Laila Woc-Colburn, MD